Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia

Abstract Background ABL1 gene translocations can be seen in precursor T-acute lymphoblastic leukemia (T-ALL). The typical translocation partner is the NUP214 gene. BCR-ABL translocations are relatively rare in this entity. Furthermore, while there have been unique patterns of amplification noted amo...

Full description

Bibliographic Details
Main Authors: Rima Koka, Najeebah A. Bade, Edward A. Sausville, Yi Ning, Ying Zou
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Molecular Cytogenetics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13039-017-0340-6
_version_ 1811223080654077952
author Rima Koka
Najeebah A. Bade
Edward A. Sausville
Yi Ning
Ying Zou
author_facet Rima Koka
Najeebah A. Bade
Edward A. Sausville
Yi Ning
Ying Zou
author_sort Rima Koka
collection DOAJ
description Abstract Background ABL1 gene translocations can be seen in precursor T-acute lymphoblastic leukemia (T-ALL). The typical translocation partner is the NUP214 gene. BCR-ABL translocations are relatively rare in this entity. Furthermore, while there have been unique patterns of amplification noted among the NUP214-ABL fusion genes, there have been few such reports among cases with BCR-ABL fusion genes. Case presentation Here we report a unique case of a 44-year old patient with T-ALL in which the blasts demonstrated a derivative chromosome 9 involving a 9;22 translocation and a dicentric Philadelphia chromosome 22 with a homogeneously staining region at the interface of the 9;22 translocation, leading to BCR-ABL1 gene amplification. Fluorescence in-situ hybridization (FISH) showed abnormal BCR/ABL1 fusions with the BCR-ABL1 gene amplification in 48% of the interphase cells analyzed. The translocation was confirmed by SNP array. Conclusions We present a novel derivative chromosome 9 that shows BCR-ABL gene fusion along with a dicentric Philadelphia chromosome 22 with BCR-ABL1 gene amplification. This is a unique pattern of BCR-ABL fusion which has never been described in T-ALL. It is significant that the patient responded to standard treatment with the CALGB 10403 protocol and supplementation with a tyrosine kinase inhibitor. Identification of additional patients with this pattern of BCR-ABL fusion will allow for enhanced risk assessment and prognostication.
first_indexed 2024-04-12T08:25:56Z
format Article
id doaj.art-e929ed700e364723a046b308da161a86
institution Directory Open Access Journal
issn 1755-8166
language English
last_indexed 2024-04-12T08:25:56Z
publishDate 2017-10-01
publisher BMC
record_format Article
series Molecular Cytogenetics
spelling doaj.art-e929ed700e364723a046b308da161a862022-12-22T03:40:23ZengBMCMolecular Cytogenetics1755-81662017-10-011011510.1186/s13039-017-0340-6Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemiaRima Koka0Najeebah A. Bade1Edward A. Sausville2Yi Ning3Ying Zou4Department of Pathology, University of Maryland School of Medicine BaltimoreDepartment of Medicine, University of Maryland School of MedicineDepartment of Medicine, University of Maryland School of MedicineDepartment of Pathology, Johns Hopkins HospitalDepartment of Pathology, University of Maryland School of Medicine BaltimoreAbstract Background ABL1 gene translocations can be seen in precursor T-acute lymphoblastic leukemia (T-ALL). The typical translocation partner is the NUP214 gene. BCR-ABL translocations are relatively rare in this entity. Furthermore, while there have been unique patterns of amplification noted among the NUP214-ABL fusion genes, there have been few such reports among cases with BCR-ABL fusion genes. Case presentation Here we report a unique case of a 44-year old patient with T-ALL in which the blasts demonstrated a derivative chromosome 9 involving a 9;22 translocation and a dicentric Philadelphia chromosome 22 with a homogeneously staining region at the interface of the 9;22 translocation, leading to BCR-ABL1 gene amplification. Fluorescence in-situ hybridization (FISH) showed abnormal BCR/ABL1 fusions with the BCR-ABL1 gene amplification in 48% of the interphase cells analyzed. The translocation was confirmed by SNP array. Conclusions We present a novel derivative chromosome 9 that shows BCR-ABL gene fusion along with a dicentric Philadelphia chromosome 22 with BCR-ABL1 gene amplification. This is a unique pattern of BCR-ABL fusion which has never been described in T-ALL. It is significant that the patient responded to standard treatment with the CALGB 10403 protocol and supplementation with a tyrosine kinase inhibitor. Identification of additional patients with this pattern of BCR-ABL fusion will allow for enhanced risk assessment and prognostication.http://link.springer.com/article/10.1186/s13039-017-0340-6T-lymphoblastic leukemiaBCR/ABLGene amplificationIsodicentric chromosome 22Derivative chromosome 9
spellingShingle Rima Koka
Najeebah A. Bade
Edward A. Sausville
Yi Ning
Ying Zou
Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
Molecular Cytogenetics
T-lymphoblastic leukemia
BCR/ABL
Gene amplification
Isodicentric chromosome 22
Derivative chromosome 9
title Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
title_full Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
title_fullStr Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
title_full_unstemmed Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
title_short Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
title_sort unique amplification of bcr abl1 gene fusion in a case of t cell acute lymphoblastic leukemia
topic T-lymphoblastic leukemia
BCR/ABL
Gene amplification
Isodicentric chromosome 22
Derivative chromosome 9
url http://link.springer.com/article/10.1186/s13039-017-0340-6
work_keys_str_mv AT rimakoka uniqueamplificationofbcrabl1genefusioninacaseoftcellacutelymphoblasticleukemia
AT najeebahabade uniqueamplificationofbcrabl1genefusioninacaseoftcellacutelymphoblasticleukemia
AT edwardasausville uniqueamplificationofbcrabl1genefusioninacaseoftcellacutelymphoblasticleukemia
AT yining uniqueamplificationofbcrabl1genefusioninacaseoftcellacutelymphoblasticleukemia
AT yingzou uniqueamplificationofbcrabl1genefusioninacaseoftcellacutelymphoblasticleukemia